19-8364622-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_139314.3(ANGPTL4):c.301G>A(p.Val101Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000195 in 1,591,080 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_139314.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANGPTL4 | NM_139314.3 | c.301G>A | p.Val101Ile | missense_variant | 1/7 | ENST00000301455.7 | NP_647475.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANGPTL4 | ENST00000301455.7 | c.301G>A | p.Val101Ile | missense_variant | 1/7 | 1 | NM_139314.3 | ENSP00000301455.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000148 AC: 3AN: 202160Hom.: 0 AF XY: 0.0000181 AC XY: 2AN XY: 110644
GnomAD4 exome AF: 0.00000834 AC: 12AN: 1438748Hom.: 0 Cov.: 32 AF XY: 0.0000112 AC XY: 8AN XY: 713692
GnomAD4 genome AF: 0.000125 AC: 19AN: 152332Hom.: 2 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 07, 2024 | The c.301G>A (p.V101I) alteration is located in exon 1 (coding exon 1) of the ANGPTL4 gene. This alteration results from a G to A substitution at nucleotide position 301, causing the valine (V) at amino acid position 101 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at